Biocomposites announce a year of record sales and company growth

Winner of two Queen’s Awards for Enterprise in Innovation and International Trade

Highest year-on-year sales growth in the company’s 25-year history

Keele, UK, 14 December 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is celebrating its 25th anniversary in a year that has seen the company deliver its highest year-on-year sales growth and, receive two prestigious Queen’s Awards for Enterprise.

Read more…

© Optimum Strategic Communications.